FDA Warnings Target Companies US-Wide For Selling CBD Products That Violate Federal Law
Executive Summary
CHART: The agency sent out 15 warning letters on 25 November, citing companies in 10 states for selling unapproved and misbranded CBD drug products in the guise of dietary supplements and cosmetics.
You may also be interested in...
CBD Drugs In Cosmetic Clothing Violate California’s Unfair Competition Law – Class Actions
California federal courts have shown themselves receptive to proposed class actions alleging that purported cosmetics carrying unapproved drug claims violate the state’s Unfair Competition Law. Plaintiffs now are testing similar theories in suits against marketers of CBD-infused topical products.
FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?
Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.
Tests Show CBD Levels In Some Supplements Don't Match Labeling
Seven of 10 CBD-containing supplement products tested in a lab did not contain the levels of CBD advertised on the label, says hemp, CBD and natural health product information publisher Remedy Reviews. Most products also were found to contain heavy metals.